Clinical Trial

Intravenous Methadone in Perioperative Acute and Chronic Management in Chinese Adult Cardiac Surgical Patients

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Despite modern day improvements in pain treatment and availability of different analgesic modalities, suboptimal postoperative pain control remains an issue in cardiac surgical patients. Poorly controlled acute postoperative pain is associated with adverse physiological outcomes that impair the recovery of cardiac surgical patients. It is associated with decreased patient satisfaction, delayed postoperative ambulation, and the development of chronic postsurgical pain (CPSP). Intravenous opioids such as fentanyl and morphine have been the mainstay of perioperative analgesia for cardiac surgery, either by intermittent boluses by healthcare staff or through a patient-controlled device (PCA). The primary problem with this mechanism of delivery is that significant fluctuations in serum opioid concentrations can occur, resulting in effects which range from inadequate analgesia to overdose and respiratory depression. In contrast to intermittent administration of short-acting opioids such as morphine and fentanyl, a single dose administration of methadone can be considered.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-06-18; most recent amendment 2025-03-25.
Status change: Recruiting → Active, Not Recruiting 2025-03-25
Status change: Not Yet Recruiting → Recruiting 2024-02-05
Trial Details
NCT Number NCT05913284
Lead Sponsor Chinese University of Hong Kong
Conditions Pain, Postoperative, Pain, Acute, Pain, Chronic, Anesthesia
Enrollment 86 participants
Start Date 2024-01-15
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-27